Cleared Special

Arm Blood Pressure Monitor (K221913) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through the Special 510(k) pathway - typically does not require clinical trials.

K221913 · Alicn Medical (Shenzhen), Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2022
Decision
104d
Days
Class 2
Risk

K221913 is an FDA 510(k) clearance for the Arm Blood Pressure Monitor. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Alicn Medical (Shenzhen), Inc. (Shenzhen, CN). The FDA issued a Cleared decision on October 12, 2022 after a review of 104 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Alicn Medical (Shenzhen), Inc. devices

Submission Details

510(k) Number K221913 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 30, 2022
Decision Date October 12, 2022
Days to Decision 104 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
21d faster than avg
Panel avg: 125d · This submission: 104d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 271
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K221913.
GUS610 Blood pressure monitor
K222160 · Globalcare Medical Technology Co., Ltd. · Nov 2022
HemoSphere Advanced Monitor, HemoSphere ClearSight Module
K221833 · Edwards Lifesciences, LLC · Nov 2022
YUWELL Electronic Blood Pressure Monitor
K221372 · Jiangsu Yuyue Medical Equipment& Supply Co., Ltd. · Oct 2022
InBody Blood pressure monitor, Model BPBIO480KV
K221764 · Inbody Co., Ltd. · Oct 2022
A&D Medical UM-212BLE Blood Pressure Monitor
K212168 · A&D Company, Ltd. · Oct 2022
Electronic Sphygmomanometer (Model: LT-P30)
K220220 · Zhuhai Linte Medical Instrument Co., Ltd. · Oct 2022